 Osteoporosis, Postmenopausal
"Osteoporosis, Postmenopausal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Descriptor ID |
D015663
|
| MeSH Number(s) |
C05.116.198.579.610
|
| Concept/Terms |
Osteoporosis, Postmenopausal- Osteoporosis, Postmenopausal
- Bone Loss, Postmenopausal
- Bone Losses, Postmenopausal
- Postmenopausal Bone Losses
- Postmenopausal Osteoporosis
- Osteoporoses, Postmenopausal
- Postmenopausal Osteoporoses
- Perimenopausal Bone Loss
- Postmenopausal Bone Loss
- Bone Loss, Perimenopausal
- Bone Losses, Perimenopausal
- Perimenopausal Bone Losses
- Osteoporosis, Post-Menopausal
- Osteoporoses, Post-Menopausal
- Osteoporosis, Post Menopausal
- Post-Menopausal Osteoporoses
- Post-Menopausal Osteoporosis
|
Below are MeSH descriptors whose meaning is more general than "Osteoporosis, Postmenopausal".
Below are MeSH descriptors whose meaning is more specific than "Osteoporosis, Postmenopausal".
This graph shows the total number of publications written about "Osteoporosis, Postmenopausal" by people in this website by year, and whether "Osteoporosis, Postmenopausal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2002 | 3 | 0 | 3 | | 2003 | 3 | 2 | 5 | | 2004 | 4 | 0 | 4 | | 2005 | 2 | 1 | 3 | | 2006 | 3 | 1 | 4 | | 2007 | 1 | 0 | 1 | | 2009 | 2 | 1 | 3 | | 2010 | 4 | 1 | 5 | | 2011 | 2 | 0 | 2 | | 2012 | 1 | 2 | 3 | | 2013 | 6 | 1 | 7 | | 2014 | 4 | 0 | 4 | | 2015 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Osteoporosis, Postmenopausal" by people in Profiles.
-
Greendale GA, Tseng CH, Han W, Huang MH, Leung K, Crawford S, Gold EB, Waetjen LE, Karlamangla AS. Dietary isoflavones and bone mineral density during midlife and the menopausal transition: cross-sectional and longitudinal results from the Study of Women's Health Across the Nation Phytoestrogen Study. Menopause. 2015 Mar; 22(3):279-88.
-
Silverman S, Curtis J, Saag K, Flahive J, Adachi J, Anderson F, Chapurlat R, Cooper C, Diez-Perez A, Greenspan S, Hooven F, Le Croix A, March L, Netelenbos JC, Nieves J, Pfeilschifter J, Rossini M, Roux C, Siris E, Watts N, Compston J. International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporos Int. 2015 Jan; 26(1):419-20.
-
Compston JE, Flahive J, Hooven FH, Anderson FA, Adachi JD, Boonen S, Chapurlat RD, Cooper C, Díez-Perez A, Greenspan SL, LaCroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Silverman S, Siris ES, Watts NB, Gehlbach SH. Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW). Calcif Tissue Int. 2014 Feb; 94(2):223-31.
-
Díez-Pérez A, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Wyman A, Rushton-Smith SK, Watts NB. Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res. 2014 Jan; 29(1):260-7.
-
FitzGerald G, Compston JE, Chapurlat RD, Pfeilschifter J, Cooper C, Hosmer DW, Adachi JD, Anderson FA, Díez-Pérez A, Greenspan SL, Netelenbos JC, Nieves JW, Rossini M, Watts NB, Hooven FH, LaCroix AZ, March L, Roux C, Saag KG, Siris ES, Silverman S, Gehlbach SH. Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). J Clin Endocrinol Metab. 2014 Mar; 99(3):817-26.
-
Costa AG, Wyman A, Siris ES, Watts NB, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, Gehlbach SH, Díez-Pérez A, Cooper C, Compston JE, Chapurlat RD, Boonen S, Anderson FA, Adachi JD, Adami S. When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS One. 2013; 8(12):e83306.
-
Kubo JT, Stefanick ML, Robbins J, Wactawski-Wende J, Cullen MR, Freiberg M, Desai M. Preference for wine is associated with lower hip fracture incidence in post-menopausal women. BMC Womens Health. 2013 Sep 22; 13:36.
-
Zhang J, Delzell E, Curtis JR, Hooven F, Gehlbach SH, Anderson FA, Saag KG. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass. Osteoporos Int. 2014 Jan; 25(1):317-24.
-
Gregson CL, Dennison EM, Compston JE, Adami S, Adachi JD, Anderson FA, Boonen S, Chapurlat R, Díez-Pérez A, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Watts NB, Wyman A, Cooper C. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int. 2014 Jan; 25(1):85-95.
-
Haring B, Pettinger M, Bea JW, Wactawski-Wende J, Carnahan RM, Ockene JK, Wyler von Ballmoos M, Wallace RB, Wassertheil-Smoller S. Laxative use and incident falls, fractures and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. BMC Geriatr. 2013 May 01; 13:38.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|